TREACE MEDICAL CONCEPTS, INC. Operating Income

Quick Answer

TREACE MEDICAL CONCEPTS, INC. reported Operating Income of -$54.15 million for fiscal year 2025.

TREACE MEDICAL CONCEPTS, INC. Operating Income — Annual History

Fiscal Year Operating Income YoY Change
2025 -$54.15M +2.8%
2024 -$55.69M -8.3%
2023 -$51.43M -47.6%
2022 -$34.84M -111.0%
2021 -$16.51M -2031.0%
2020 $855.0K +124.2%
2019 -$3.54M

Quarterly Operating Income

Quarter Ending Operating Income YoY QoQ
September 30, 2025 -$15.68M -3.6% +7.6%
June 30, 2025 -$16.97M +20.6% -8.9%
March 31, 2025 -$15.58M +17.9% -3.0%
September 30, 2024 -$15.13M +15.1% +29.2%
June 30, 2024 -$21.38M -63.8% -12.7%
March 31, 2024 -$18.97M -37.7% -6.5%
September 30, 2023 -$17.82M -57.4% -36.5%
June 30, 2023 -$13.05M -9.4% +5.3%
  • TREACE MEDICAL CONCEPTS, INC. showed an increase of +2.8% in Operating Income compared to the prior fiscal year.
  • Over the 2019–2025 period, TREACE MEDICAL CONCEPTS, INC.’s operating income has declined by 1431.9% (from -$3.54 million to -$54.15 million).
  • The most recent figure is from TREACE MEDICAL CONCEPTS, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 27, 2026.
  • All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.

Last verified:

Leave a Comment